Science-backed articles on peptide research, mechanisms, and the latest findings from our research team.
TB-500 (thymosin beta 4) is gaining attention for its potential cognitive benefits through neuroinflammation reduction. While animal research shows promise, human clinical trials are only now beginning. Learn how this peptide may work and what the current evidence actually shows.
